Sébastien Hébert
Chercheur universitaire
Axe Neurosciences
Publications
View all-
article Lala Bouali M, Kezai AM, Bazin M, Badiane PY, Eskandari N, Lévesque V, Robillard J, Côté SD, Soulet D, Tremblay C, Calon F, Morin F, Vallières L, Hébert SS
Natural microbial enrichment modulates microglial states and transcriptional programs relevant to Alzheimers disease
Front Immunol 17 2026.
-
article Calon F, Otaegui L, Bouali ML, Hébert SS
Are mouse models of Alzheimers disease truly flawed, or are we misusing them
Neuroscience 614 2026.
-
article Cottez RJ, Peyrot C, Denis HL, Tremblay C, Loiselle A, Dallaire-Théroux C, Filali-Mouhim A, Hébert SS, Leclerc N, Blennow K, Zetterberg H and and Kergoat MJ, Calon F, Pichet Binette A
Plasma p-tau markers, vascular factors, and cognitive decline in the CIMA-Q cohort
Alzheimers Dement 22 (6), 2026.
Projects
- Preclinical safety, pharmacokinetics, pharmacodynamics, and efficiency of microRNA oligonucleotides for Alzheimer's disease, from 2022-04-01 to 2027-03-31
- Consortium pour l’identification précoce de la maladie d’Alzheimer (CIMA-Q) : renforcer l’intersectorialité, le rayonnement et le potentiel de découverte., from 2024-04-01 to 2028-03-31
- Into the (re-) wild: moving beyond lab-raised mice in order to make EAE more reflective of human MS, from 2026-04-01 to 2028-03-31
- Rewilding Alzheimer’s Research: Investigating the Role of Natural Immunity in Disease Progression and Therapeutic Efficacy, from 2026-10-01 to 2031-09-30
- Preclinical safety, pharmacokinetics, pharmacodynamics, and efficiency of microRNA oligonucleotides for Alzheimer's disease, from 2020-03-01 to 2025-03-31
- Importance of non-canonical microRNAs in the mammalian brain, from 2020-04-01 to 2026-03-31
- Vascular MicroRNA-212 in CAA and Alzheimer's disease, from 2023-09-22 to 2025-08-31